{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:03:19Z","timestamp":1792180999281,"version":"4.4.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,19]]},"DOI":"10.7759\/cureus.74048","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T04:35:19Z","timestamp":1732077319000},"source":"Crossref","is-referenced-by-count":4,"title":["Role of Neurotrophins in the Development and Treatment of Neurodegenerative Diseases: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Sadia","family":"Mansoor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anushka","family":"Jindal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana Yaw Afriyie","family":"Badu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiko","family":"Katiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V Jaswitha S","family":"Ponnapalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kesha J","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sondos T","family":"Nassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of neurodegenerative diseases","volume":"186","author":"Wilson DM 3rd","year":"2023","unstructured":"Wilson DM 3rd, Cookson MR, Van Den Bosch L, Zetterberg H, Holtzman DM, Dewachter I. Hallmarks of neurodegenerative diseases. Cell. 2023, 186:693-714. 10.1016\/j.cell.2022.12.032","journal-title":"Cell"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-022-00279-0","article-title":"Brain-derived neurotrophic factor in Alzheimer's disease and its pharmaceutical potential","volume":"11","author":"Gao L","year":"2022","unstructured":"Gao L, Zhang Y, Sterling K, Song W. Brain-derived neurotrophic factor in Alzheimer's disease and its pharmaceutical potential. Transl Neurodegener. 2022, 11:4. 10.1186\/s40035-022-00279-0","journal-title":"Transl Neurodegener"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10051143","article-title":"Brain-derived neurotropic factor in neurodegenerative disorders","volume":"10","author":"Ibrahim AM","year":"2022","unstructured":"Ibrahim AM, Chauhan L, Bhardwaj A, et al.. Brain-derived neurotropic factor in neurodegenerative disorders. Biomedicines. 2022, 10:10.3390\/biomedicines10051143","journal-title":"Biomedicines"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23126827","article-title":"Recent advances on the role of brain-derived neurotrophic factor (BDNF) in neurodegenerative diseases","volume":"23","author":"Azman KF","year":"2022","unstructured":"Azman KF, Zakaria R. Recent advances on the role of brain-derived neurotrophic factor (BDNF) in neurodegenerative diseases. Int J Mol Sci. 2022, 23:10.3390\/ijms23126827","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4252\/wjsc.v12.i5.323","article-title":"Advances in treatment of neurodegenerative diseases: pespectives for combination of stem cells with neurotrophic factors","volume":"12","author":"Wang J","year":"2020","unstructured":"Wang J, Hu WW, Jiang Z, Feng MJ. Advances in treatment of neurodegenerative diseases: pespectives for combination of stem cells with neurotrophic factors. World J Stem Cells. 2020, 12:323-38. 10.4252\/wjsc.v12.i5.323","journal-title":"World J Stem Cells"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/med.21794","article-title":"Neurodegenerative disorders-searching for targets and new ways of diseases treatment","volume":"41","author":"Abramov AY","year":"2021","unstructured":"Abramov AY, Bachurin SO. Neurodegenerative disorders-searching for targets and new ways of diseases treatment. Med Res Rev. 2021, 41:2603-5. 10.1002\/med.21794","journal-title":"Med Res Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/s0165-0173(98)00004-6","article-title":"The role of neuronal growth factors in neurodegenerative disorders of the human brain","volume":"27","author":"Connor B","year":"1998","unstructured":"Connor B, Dragunow M. The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res Rev. 1998, 27:1-39. 10.1016\/s0165-0173(98)00004-6","journal-title":"Brain Res Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2022.07.003","article-title":"Neurotrophin-targeted therapeutics: a gateway to cognition and more?","volume":"27","author":"Nordvall G","year":"2022","unstructured":"Nordvall G, Forsell P, Sandin J. Neurotrophin-targeted therapeutics: a gateway to cognition and more?. Drug Discov Today. 2022, 27:103318. 10.1016\/j.drudis.2022.07.003","journal-title":"Drug Discov Today"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s41073-019-0064-8","article-title":"SANRA-a scale for the quality assessment of narrative review articles","volume":"4","author":"Baethge C","year":"2019","unstructured":"Baethge C, Goldbeck-Wood S, Mertens S. SANRA-a scale for the quality assessment of narrative review articles. Res Integr Peer Rev. 2019, 4:5. 10.1186\/s41073-019-0064-8","journal-title":"Res Integr Peer Rev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea BJ","year":"2017","unstructured":"Shea BJ, Reeves BC, Wells G, et al.. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017, 358:j4008. 10.1136\/bmj.j4008","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins JP","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, et al.. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011, 343:d5928. 10.1136\/bmj.d5928","journal-title":"BMJ"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang A","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010, 25:603-5. 10.1007\/s10654-010-9491-z","journal-title":"Eur J Epidemiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18368","article-title":"BDNF\/TrkB activators in Parkinson's disease: a new therapeutic strategy","volume":"28","author":"Ali NH","year":"2024","unstructured":"Ali NH, Al-Kuraishy HM, Al-Gareeb AI, et al.. BDNF\/TrkB activators in Parkinson's disease: a new therapeutic strategy. J Cell Mol Med. 2024, 28:e18368. 10.1111\/jcmm.18368","journal-title":"J Cell Mol Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2017.0717","article-title":"BDNF polymorphism: a review of its diagnostic and clinical relevance in neurodegenerative disorders","volume":"9","author":"Shen T","year":"2018","unstructured":"Shen T, You Y, Joseph C, Mirzaei M, Klistorner A, Graham SL, Gupta V. BDNF polymorphism: a review of its diagnostic and clinical relevance in neurodegenerative disorders. Aging Dis. 2018, 9:523-36. 10.14336\/AD.2017.0717","journal-title":"Aging Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21207777","article-title":"Neurotrophic factor BDNF, physiological functions and therapeutic potential in depression, neurodegeneration and brain cancer","volume":"21","author":"Colucci-D'Amato L","year":"2020","unstructured":"Colucci-D'Amato L, Speranza L, Volpicelli F. Neurotrophic factor BDNF, physiological functions and therapeutic potential in depression, neurodegeneration and brain cancer. Int J Mol Sci. 2020, 21:10.3390\/ijms21207777","journal-title":"Int J Mol Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20020257","article-title":"Decreased serum brain-derived neurotrophic factor (BDNF) levels in patients with Alzheimer's disease (AD): a systematic review and meta-analysis","volume":"20","author":"Ng TK","year":"2019","unstructured":"Ng TK, Ho CS, Tam WW, Kua EH, Ho RC. Decreased serum brain-derived neurotrophic factor (BDNF) levels in patients with Alzheimer's disease (AD): a systematic review and meta-analysis. Int J Mol Sci. 2019, 20:10.3390\/ijms20020257","journal-title":"Int J Mol Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s43440-020-00120-3","article-title":"Neurotrophic factors for disease-modifying treatments of Parkinson's disease: gaps between basic science and clinical studies","volume":"72","author":"Chmielarz P","year":"2020","unstructured":"Chmielarz P, Saarma M. Neurotrophic factors for disease-modifying treatments of Parkinson's disease: gaps between basic science and clinical studies. Pharmacol Rep. 2020, 72:1195-217. 10.1007\/s43440-020-00120-3","journal-title":"Pharmacol Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/biom12101409","article-title":"Alzheimer's disease: challenges and a therapeutic opportunity to treat it with a neurotrophic compound","volume":"12","author":"Baazaoui N","year":"2022","unstructured":"Baazaoui N, Iqbal K. Alzheimer's disease: challenges and a therapeutic opportunity to treat it with a neurotrophic compound. Biomolecules. 2022, 12:10.3390\/biom12101409","journal-title":"Biomolecules"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1515\/revneuro-2021-0111","article-title":"The role of brain-derived neurotrophic factor and the neurotrophin receptor p75NTR in age-related brain atrophy and the transition to Alzheimer's disease","volume":"33","author":"Cade S","year":"2022","unstructured":"Cade S, Zhou XF, Bobrovskaya L. The role of brain-derived neurotrophic factor and the neurotrophin receptor p75NTR in age-related brain atrophy and the transition to Alzheimer's disease. Rev Neurosci. 2022, 33:515-29. 10.1515\/revneuro-2021-0111","journal-title":"Rev Neurosci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2015.1807","article-title":"Nerve growth factor gene therapy: activation of neuronal responses in Alzheimer disease","volume":"72","author":"Tuszynski MH","year":"2015","unstructured":"Tuszynski MH, Yang JH, Barba D, et al.. Nerve growth factor gene therapy: activation of neuronal responses in Alzheimer disease. JAMA Neurol. 2015, 72:1139-47. 10.1001\/jamaneurol.2015.1807","journal-title":"JAMA Neurol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2018.0233","article-title":"Adeno-associated viral vector (serotype 2)-nerve growth factor for patients with Alzheimer disease: a randomized clinical trial","volume":"75","author":"Rafii MS","year":"2018","unstructured":"Rafii MS, Tuszynski MH, Thomas RG, et al.. Adeno-associated viral vector (serotype 2)-nerve growth factor for patients with Alzheimer disease: a randomized clinical trial. JAMA Neurol. 2018, 75:834-41. 10.1001\/jamaneurol.2018.0233","journal-title":"JAMA Neurol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104540","article-title":"Brain-derived neurotrophic factor (BDNF) and TrkB hippocampal gene expression are putative predictors of neuritic plaque and neurofibrillary tangle pathology","volume":"132","author":"Ginsberg SD","year":"2019","unstructured":"Ginsberg SD, Malek-Ahmadi MH, Alldred MJ, et al.. Brain-derived neurotrophic factor (BDNF) and TrkB hippocampal gene expression are putative predictors of neuritic plaque and neurofibrillary tangle pathology. Neurobiol Dis. 2019, 132:104540. 10.1016\/j.nbd.2019.104540","journal-title":"Neurobiol Dis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2018.07.010","article-title":"Serum level of brain-derived neurotrophic factor in Parkinson's disease: a meta-analysis","volume":"88","author":"Jiang L","year":"2019","unstructured":"Jiang L, Zhang H, Wang C, Ming F, Shi X, Yang M. Serum level of brain-derived neurotrophic factor in Parkinson's disease: a meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2019, 88:168-74. 10.1016\/j.pnpbp.2018.07.010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111702","article-title":"Mechanistic insight from preclinical models of Parkinson's disease could help redirect clinical trial efforts in GDNF therapy","volume":"22","author":"Delgado-Minjares KM","year":"2021","unstructured":"Delgado-Minjares KM, Martinez-Fong D, Mart\u00ednez-D\u00e1vila IA, et al.. Mechanistic insight from preclinical models of Parkinson's disease could help redirect clinical trial efforts in GDNF therapy. Int J Mol Sci. 2021, 22:10.3390\/ijms222111702","journal-title":"Int J Mol Sci"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/154955","article-title":"A meta-analysis on the role of brain-derived neurotrophic factor in Parkinson's disease patients","volume":"32","author":"Chen Z","year":"2023","unstructured":"Chen Z, Zhang H. A meta-analysis on the role of brain-derived neurotrophic factor in Parkinson's disease patients. Adv Clin Exp Med. 2023, 32:285-95. 10.17219\/acem\/154955","journal-title":"Adv Clin Exp Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/311116-role-of-neurotrophins-in-the-development-and-treatment-of-neurodegenerative-diseases-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T04:35:21Z","timestamp":1732077321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/311116-role-of-neurotrophins-in-the-development-and-treatment-of-neurodegenerative-diseases-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,19]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.74048","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,19]]}}}